Stock 3540 C.I. MEDICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials C.I. Medical Co.,Ltd.

Equities

3540

JP3346190006

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 01:59:36 2024-06-28 EDT 		5-day change 1st Jan Change
921 JPY -0.54% Intraday chart for C.I. Medical Co.,Ltd. -1.92% +9.64%
05-10 7-Eleven Operator Seven & i Selling Nissen to Ci Medical MT
05-09 C.I. Medical Co.,Ltd. signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 30,900 63,100 46,350 50,599 41,999 46,049 - -
Enterprise Value (EV) 1 28,451 57,420 42,669 55,865 57,388 46,049 46,049 46,049
P/E ratio 20.5 x 21.6 x 16.4 x 20.1 x 20.2 x 18.8 x 15.6 x 12.8 x
Yield 0.49% 0.93% 0.61% 0.5% 0.6% 0.65% 0.72% 0.83%
Capitalization / Revenue 1.07 x 1.69 x 1.12 x 1.18 x 0.92 x 0.91 x 0.82 x 0.72 x
EV / Revenue 1.07 x 1.69 x 1.12 x 1.18 x 0.92 x 0.91 x 0.82 x 0.72 x
EV / EBITDA 12.9 x 12.7 x 9.52 x 11.6 x - 9.35 x 7.98 x 6.9 x
EV / FCF 23,824,208 x 18,581,909 x -31,466,163 x -5,856,422 x - - - -
FCF Yield 0% 0% -0% -0% - - - -
Price to Book 2.82 x 4.59 x 2.9 x 2.78 x 2.09 x 2.07 x 1.85 x 1.63 x
Nbr of stocks (in thousands) 50,000 50,000 50,000 49,999 49,999 49,999 - -
Reference price 2 618.0 1,262 927.0 1,012 840.0 921.0 921.0 921.0
Announcement Date 2/13/20 2/12/21 2/10/22 2/14/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 28,763 37,393 41,205 42,891 45,628 50,350 56,200 64,200
EBITDA 1 2,389 4,975 4,868 4,368 - 4,923 5,773 6,673
EBIT 1 2,100 4,702 4,523 3,990 2,989 3,550 4,300 5,200
Operating Margin 7.3% 12.57% 10.98% 9.3% 6.55% 7.05% 7.65% 8.1%
Earnings before Tax (EBT) 1 2,149 4,450 4,285 3,851 3,184 3,620 4,400 5,300
Net income 1 1,505 2,920 2,820 2,521 2,082 2,450 2,950 3,600
Net margin 5.23% 7.81% 6.84% 5.88% 4.56% 4.87% 5.25% 5.61%
EPS 2 30.11 58.42 56.42 50.43 41.65 49.00 59.00 72.00
Free Cash Flow 1,297 3,396 -1,473 -8,640 - - - -
FCF margin 4.51% 9.08% -3.57% -20.14% - - - -
FCF Conversion (EBITDA) 54.3% 68.26% - - - - - -
FCF Conversion (Net income) 86.18% 116.29% - - - - - -
Dividend per Share 2 3.012 11.68 5.642 5.044 5.044 6.000 6.600 7.600
Announcement Date 2/13/20 2/12/21 2/10/22 2/14/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales 1 14,990 16,974 20,419 20,414 10,605 20,791 10,417 10,546 20,963 10,505 11,423 21,928 10,999 11,198 22,197 11,451 11,946 11,950 23,900 12,870 13,580 26,450
EBITDA - - - - - - - - - - - - - - - - - - - - - -
EBIT 1 1,108 1,785 2,917 2,546 970 1,977 1,294 1,031 2,325 849 816 1,665 786 982 1,768 780 407 660 1,080 1,580 990 2,570
Operating Margin 7.39% 10.52% 14.29% 12.47% 9.15% 9.51% 12.42% 9.78% 11.09% 8.08% 7.14% 7.59% 7.15% 8.77% 7.97% 6.81% 3.41% 5.52% 4.52% 12.28% 7.29% 9.72%
Earnings before Tax (EBT) 1 1,129 1,733 2,717 2,358 925 1,927 1,312 1,006 2,318 882 651 1,533 814 1,079 1,893 799 393 643 1,050 1,640 930 2,570
Net income 1 788 1,136 1,784 1,550 611 1,270 869 659 1,528 570 423 993 521 705 1,226 513 247 433 680 1,020 750 1,770
Net margin 5.26% 6.69% 8.74% 7.59% 5.76% 6.11% 8.34% 6.25% 7.29% 5.43% 3.7% 4.53% 4.74% 6.3% 5.52% 4.48% 2.07% 3.62% 2.85% 7.93% 5.52% 6.69%
EPS - 22.72 - 31.00 - - 17.38 - 30.57 11.39 - - 10.42 - 24.53 10.26 4.952 - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - - - -
Announcement Date 2/13/20 8/11/20 2/12/21 8/10/21 2/10/22 2/10/22 5/10/22 8/9/22 8/9/22 11/8/22 2/14/23 2/14/23 5/9/23 8/8/23 8/8/23 11/13/23 5/14/24 - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - 5,266 15,389 - - -
Net Cash position 2,449 5,680 3,681 - - - - -
Leverage (Debt/EBITDA) - - - 1.206 x - - - -
Free Cash Flow 1,297 3,396 -1,473 -8,640 - - - -
ROE (net income / shareholders' equity) 14.7% 23.7% 19% 14.7% 10.9% 11.5% 12.5% 13.5%
ROA (Net income/ Total Assets) 16.6% 29.1% 23.7% 15.5% 9.19% 9.7% 13.3% 15.1%
Assets 1 9,076 10,033 11,884 16,239 22,650 25,258 22,180 23,841
Book Value Per Share 2 219.0 275.0 320.0 364.0 401.0 445.0 498.0 564.0
Cash Flow per Share 35.90 63.80 63.30 58.00 60.60 - - -
Capex 1 105 459 2,831 8,914 8,852 2,000 1,000 1,000
Capex / Sales 0.37% 1.23% 6.87% 20.78% 19.4% 3.97% 1.78% 1.56%
Announcement Date 2/13/20 2/12/21 2/10/22 2/14/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for C.I. Medical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
C.I. MEDICAL CO.,LTD. Stock C.I. Medical Co.,Ltd.
+9.64% 286M
COLOPLAST A/S Stock Coloplast A/S
+8.37% 27.03B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+14.77% 2.39B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-51.12% 2.18B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-32.08% 2.03B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
+22.22% 1.87B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-18.71% 1.71B
NAKANISHI INC. Stock Nakanishi Inc.
+7.63% 1.34B
KOSSAN RUBBER INDUSTRIES Stock Kossan Rubber Industries
+27.03% 1.27B
GVS S.P.A. Stock GVS S.p.A.
+17.85% 1.23B
Medical Supplies
  1. Stock Market
  2. Equities
  3. 3540 Stock
  4. Financials C.I. Medical Co.,Ltd.